Exact Sciences
Exact Sciences raises $125M Series D at $1.5B valuation
Quick Facts
Exact Sciences: Series D Funding Round
Exact Sciences has successfully raised $125M in Series D funding, reaching a valuation of $1.5B.
Company Overview
Cancer screening and diagnostics
Funding Details
The Series D round was led by Casdin Capital, with participation from Fidelity.
Company Information
- Headquarters: Madison, WI
- Founded: 1995
- Employees: 5000+
- Category: Biotech
Investment
Exact Sciences plans to use the funds to accelerate product development, expand its team, and scale operations globally.
About the Investors
- Casdin Capital: Verified investor in Series D
- Fidelity: Verified investor in Series D
Key Investors
About the Author
Related Company Reports
Arthrosi Therapeutics raises $153M Series E at $800M valuation
Arthrosi Therapeutics raises $153M in Series E at $800M valuation. Developing next-generation gout treatment drug for chronic conditions...
HorizonStudio Raises $100M Growth to Transform Biotech
HorizonStudio has secured $100M Growth in funding to accelerate growth and innovation. Leading artificial intelligence infrastructure enabling scalable ML deployment for businesses...
StreamData Raises $15M Seed to Transform Biotech
StreamData has secured $15M Seed in funding to accelerate growth and innovation. Leading artificial intelligence infrastructure enabling scalable ML deployment for businesses...
